Lukasz Wojciech

Lukasz Wojciech

Auto-generated profile, based on publicly available information

Lukasz Wojciech

Immunology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
LDLei Deng
Lei Deng
LWLukasz Wojciech
Lukasz Wojciech
NGNicholas Robert John Gascoigne
Nicholas Robert John Gascoigne
GPGuangneng Peng
Guangneng Peng
KTKevin S.w. Tan
Kevin S.w. Tan
The human gut microbiota is a diverse and complex ecosystem that is involved in beneficial physiological functions as well as disease pathogenesis. Blastocystis is a common protistan parasite and is increasingly recognized as an important component of the gut microbiota. The correlations between Blastocystis and other communities of intestinal microbiota have been investigated, and, to a lesser extent, the role of this parasite in maintaining the host immunological homeostasis. Despite recent studies suggesting that Blastocystis decreases the abundance of beneficial bacteria, most reports indicate that Blastocystis is a common component of the healthy gut microbiome. This review covers recent finding on the potential interactions between Blastocystis and the gut microbiota communities and its roles in regulating host immune responses.

4 June 2021 in Science
Verified
Journal Article
Closed access
PDF file
PZPirooz Zareie
Pirooz Zareie
CSChristopher Szeto
Christopher Szeto
CFCarine Farenc
Carine Farenc
SGSachith D. Gunasinghe
Sachith D. Gunasinghe
EKElizabeth Motunrayo Kolawole
Elizabeth Motunrayo Kolawole
NGNicole La Gruta
Nicole La Gruta
Making sense of TCR–pMHC topology: Most T cells use a T cell receptor (TCR) that recognizes major histocompatibility complex molecules bound to peptides (pMHCs) derived from both self- and foreign antigens. Although there is great variability in the interface because of the diversity of both partners, this interaction displays a canonical docking topology for reasons that remain contested. Zareie et al. tested an assortment of both canonical and reversed-polarity TCRs that were all specific for the same cognate pMHC-I bearing a peptide derived from influenza A virus (IAV) (see the Perspective by Horkova and Stepanek). The authors determined that docking topology was the primary driver of in vivo T cell activation and recruitment when mice were infected with IAV. The canonical topology was required for the formation of a functional signaling complex, suggesting that T cell signaling constraints dictate how TCR and pMHC meet. Science , abe9124, this issue p. eabe9124 ; see also abj2937, p. 1038

25 September 2023 in The EMBO Journal
Verified
Journal Article
Open access
LWLukasz Wojciech
Lukasz Wojciech
CPChin Wen Png
Chin Wen Png
EKEileen Koh
Eileen Koh
DKDorinda Yan Qin Kioh
Dorinda Yan Qin Kioh
LDLei Deng
Lei Deng
NGNicholas Robert John Gascoigne
Nicholas Robert John Gascoigne
The large intestine harbors microorganisms playing unique roles in host physiology. The beneficial or detrimental outcome of host-microbiome coexistence depends largely on the balance between regulators and responder intestinal CD4+ T cells. We found that ulcerative colitis-like changes in the large intestine after infection with the protist Blastocystis ST7 in a mouse model are associated with reduction of anti-inflammatory Treg cells and simultaneous expansion of pro-inflammatory Th17 responders. These alterations in CD4+ T cells depended on the tryptophan metabolite indole-3-acetaldehyde (I3AA) produced by this single-cell eukaryote. I3AA reduced the Treg subset in vivo and iTreg development in vitro by modifying their sensing of TGFβ, concomitantly affecting recognition of self-flora antigens by conventional CD4+ T cells. Parasite-derived I3AA also induces over-exuberant TCR signaling, manifested by increased CD69 expression and downregulation of co-inhibitor PD-1. We have thus identified a new mechanism dictating CD4+ fate decisions. The findings thus shine a new light on the ability of the protist microbiome and tryptophan metabolites, derived from them or other sources, to modulate the adaptive immune compartment, particularly in the context of gut inflammatory disorders.